Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

NCT01335204 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Prostate Cancer
Prostatic Neoplasms

Interventions

DRUG: Cabazitaxel plus bavituximab

Sponsor

Medical University of South Carolina

Collaborators

[object Object]